COVID-19 Can't Delay Juul & Altria Trial, FTC Staff Says
Federal Trade Commission staffers urged the commission not to delay an upcoming in-house virtual trial against tobacco manufacturer Altria's $12.8 billion investment in electronic cigarette company Juul, calling hopes of an in-person,...To view the full article, register now.
Already a subscriber? Click here to view full article